Spirea Limited is a Cambridge-based company created to advance a new generation of antibody-targeted cancer treatments with significantly better efficacy and safety profiles. Spirea will use its innovative technology to enable a pipeline of superior and differentiated antibody drug conjugates for the treatment of a range of solid tumours.



Biotechnology

Research

Spirea

Spirea's headquarters in Cambridge, MA, United States

Myriam Ouberai

Adam Collier

Paul Varley

Rakesh Dixit

John Hartley

Anthony Tolcher

Jane Dancer

Gaynor Fryers

Barbara Domayne-Hayman

Christine Martin

Mike Murphy

The Governance Team at Spirea Limited is responsible for guiding and overseeing the company’s strategic direction, ensuring regulatory compliance, and maintaining high ethical standards. Comprising advisors and board members, the team provides expert advice, risk management, and crucial decision-making support to advance Spirea's mission of developing innovative antibody-targeted cancer therapies.

Governance Team

The Leadership Team at Spirea is responsible for setting the strategic direction of the company, fostering innovation in antibody-targeted cancer treatments, and driving business development initiatives. Comprised of senior executives, including the CEO and Chief Business Officers, the team collaborates to ensure alignment between scientific advancement and market needs, ultimately aiming to enhance the efficacy and safety profiles of novel therapies for solid tumors.

Leadership Team

Spirea

Org chart

Board & advisors

Teams

Governance Team

Leadership Team

Offices

Spirea

Org chart

Board & advisors

Teams

Governance Team

Leadership Team

Offices

Related companies